GLUT

亜型選択性的な製品

GLUT製品

  • All (6)
  • GLUT阻害剤 (6)
  • 新製品
製品コード 製品名称 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S8452 BAY-876 BAY-876 is a potent and selective GLUT1 inhibitor (IC50=0.002 μM) with a selectivity factor of >100 against GLUT2, GLUT3, and GLUT4.
Am J Pathol, 2024, S0002-9440(24)00116-0
Cancer Cell Int, 2024, 24(1):19
Nat Commun, 2023, 14(1):2894
S7931 STF-31 STF-31 is a selective glucose transporter GLUT1 inhibitor.
Immunity, 2022, 55(1):159-173.e9
J Control Release, 2022, 352:540-555
Mol Oncol, 2022, 16(15):2861-2880
S7927 WZB117 WZB117 is an inhibitor of Glucose Transporter 1 (GLUT1). It inhibited cell proliferation in lung cancer A549 cells and breast cancer MCF7 cells with an IC50 of approximately 10 μM.
Am J Pathol, 2024, S0002-9440(24)00116-0
Cell Rep, 2023, 42(3):112186
Cancer Lett, 2022, S0304-3835(22)00321-4
E0805 KL-11743 KL-11743 is a potent glucose-competitive inhibitor of the class I glucose transporters with IC50s of 115, 137 and 90 nM for GLUT1, GLUT2, and GLUT3.
S5748 4′-Deoxyphlorizin 4'-Deoxyphlorizin is an inhibitor of the glucose transport system.
S0235 Lavendustin B Lavendustin B inhibits HIV-1 integrase (IN) interaction with its cognate cellular cofactor lens epithelium-derived growth factor (LEDGF/p75). Lavendustin B is an inhibitor of Tyrosine Kinase and also a competitive inhibitor of glucose transporter 1 (Glut1).
S8452 BAY-876 BAY-876 is a potent and selective GLUT1 inhibitor (IC50=0.002 μM) with a selectivity factor of >100 against GLUT2, GLUT3, and GLUT4.
Am J Pathol, 2024, S0002-9440(24)00116-0
Cancer Cell Int, 2024, 24(1):19
Nat Commun, 2023, 14(1):2894
S7931 STF-31 STF-31 is a selective glucose transporter GLUT1 inhibitor.
Immunity, 2022, 55(1):159-173.e9
J Control Release, 2022, 352:540-555
Mol Oncol, 2022, 16(15):2861-2880
S7927 WZB117 WZB117 is an inhibitor of Glucose Transporter 1 (GLUT1). It inhibited cell proliferation in lung cancer A549 cells and breast cancer MCF7 cells with an IC50 of approximately 10 μM.
Am J Pathol, 2024, S0002-9440(24)00116-0
Cell Rep, 2023, 42(3):112186
Cancer Lett, 2022, S0304-3835(22)00321-4
E0805 KL-11743 KL-11743 is a potent glucose-competitive inhibitor of the class I glucose transporters with IC50s of 115, 137 and 90 nM for GLUT1, GLUT2, and GLUT3.
S5748 4′-Deoxyphlorizin 4'-Deoxyphlorizin is an inhibitor of the glucose transport system.
S0235 Lavendustin B Lavendustin B inhibits HIV-1 integrase (IN) interaction with its cognate cellular cofactor lens epithelium-derived growth factor (LEDGF/p75). Lavendustin B is an inhibitor of Tyrosine Kinase and also a competitive inhibitor of glucose transporter 1 (Glut1).

GLUT阻害剤の選択性比較

Tags: GLUT inhibitor|GLUT agonist|GLUT activator|GLUT inducer|GLUT antagonist|GLUT signaling pathway|GLUT assay kit